# China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension

> **NCT03532620** · PHASE4 · UNKNOWN · sponsor: **Jun Tao** · enrollment: 396 (estimated)

## Conditions studied

- Prediabetic State
- Hypertension
- Dyslipidemias

## Interventions

- **DRUG:** Pitavastatin Calcium
- **DRUG:** Atorvastatin Calcium

## Key facts

- **NCT ID:** NCT03532620
- **Lead sponsor:** Jun Tao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-09
- **Primary completion:** 2019-09
- **Final completion:** 2020-09
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2019-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532620, "China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03532620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*